Drug Profile
Carmegliptin - Roche/Chugai
Alternative Names: DPP-IV(3); R 1579; RG 1579; RO 4876904-001Latest Information Update: 22 Jan 2010
Price :
$50
*
At a glance
- Originator Roche
- Developer Chugai Pharmaceutical; Roche
- Class 3-ring heterocyclic compounds; Antihyperglycaemics; Pyrrolidinones; Small molecules
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 30 Sep 2007 Phase-II clinical trials in Type-2 diabetes mellitus in Europe (PO)
- 19 Sep 2006 Phase-I clinical trials in Type-2 diabetes mellitus in Europe (PO)